Search research articles
Contact Us
Filters
Showing results (91-100 of 242) with videos related to
Page
of 25
Sort By:
Pharmaceutical Medicine
|
June 18, 2026
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Laura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Journal of Neuro-Oncology
|
October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
Till Milde, Marco Lodrini, Larissa Savelyeva, et al.
Clinical Pharmacology and Therapeutics
|
July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies
Nora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Cancer Research
|
January 22, 2009
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice
Ines Ecke, Frauke Petry, Albert Rosenberger, et al.
Neuro-Oncology Advances
|
April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
Sonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
JCO Precision Oncology
|
January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets
Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
International Journal of Cancer
|
October 16, 2019
Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort
Johannes Holzapfel, Daniela Kandels, René Schmidt, et al.
Journal of Medicinal Chemistry
|
December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
Tino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Cancer Medicine
|
June 26, 2024
Adaption of neurosurgical resection patterns for pediatric low-grade glioma spanning two decades-Report from the German LGG-studies 1996-2018
Tibor Kelety, Ulrich-Wilhelm Thomale, Daniela Kandels, et al.
Chemmedchem
|
April 30, 2020
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors
Michael Morgen, Raphael R Steimbach, Magalie Géraldy, et al.
Page
of 25
Search research articles
Search
Showing results (91-100 of 242) with videos related to
Sort By:
Page
of 25
Pharmaceutical Medicine
|
June 18, 2026
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Laura Fankhauser, Franca Ligas, Giovanni Lesa, et al.
Journal of Neuro-Oncology
|
October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
Till Milde, Marco Lodrini, Larissa Savelyeva, et al.
Clinical Pharmacology and Therapeutics
|
July 13, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies
Nora Jamaladdin, Romain Sigaud, Daniela Kocher, et al.
Cancer Research
|
January 22, 2009
Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice
Ines Ecke, Frauke Petry, Albert Rosenberger, et al.
Neuro-Oncology Advances
|
April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
Sonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
JCO Precision Oncology
|
January 7, 2022
<i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets
Elke Pfaff, Tiphaine Adam de Beaumais, Antonin Marchais, et al.
International Journal of Cancer
|
October 16, 2019
Favorable prognosis in pediatric brainstem low-grade glioma: Report from the German SIOP-LGG 2004 cohort
Johannes Holzapfel, Daniela Kandels, René Schmidt, et al.
Journal of Medicinal Chemistry
|
December 1, 2017
Structure-Based Design and Biological Characterization of Selective Histone Deacetylase 8 (HDAC8) Inhibitors with Anti-Neuroblastoma Activity
Tino Heimburg, Fiona R Kolbinger, Patrik Zeyen, et al.
Cancer Medicine
|
June 26, 2024
Adaption of neurosurgical resection patterns for pediatric low-grade glioma spanning two decades-Report from the German LGG-studies 1996-2018
Tibor Kelety, Ulrich-Wilhelm Thomale, Daniela Kandels, et al.
Chemmedchem
|
April 30, 2020
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors
Michael Morgen, Raphael R Steimbach, Magalie Géraldy, et al.
Page
of 25